CDC logoSafer Healthier People  CDC HomeCDC SearchCDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Skip navigation links Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us

Search for NIOSH Publications: NIOSHTIC-2

NIOSHTIC-2 Search Results

      Advanced Search  |  Help  |  About  |  Feedback 
Terms: Issues in neurological risk assessment 1 - 1 of 2 Bibliographic entries
Save All   |   Save Page View Saved    |    Download
Select check boxes to automatically save entries, or use 'save all' or 'save page' links above.

 1 Issues in neurological risk assessment for occupational exposures: the Bay Bridge welders
Authors Park-RM; Bowler-RM; Eggerth-DE; Diamond-E; Spencer-KJ; Smith-D; Gwiazda-R 
Source Neurotoxicology 2006 May; 27(3):373-384 
Link http://dx.doi.org/10.1016/j.neuro.2005.10.010 
NIOSHTIC No. 20030361 
AbstractThe goal of occupational risk assessment is often to estimate excess lifetime risk for some disabling or fatal health outcome in relation to a fixed workplace exposure lasting a working lifetime. For sub-chronic or sub-clinical health effects measured as continuous variables, the benchmark dose method can be applied, but poses issues in defining impairment and in specifying acceptable levels of excess risk. Such risks may also exhibit a dose-rate effect and partial reversibility such that effects depend on how the dose is distributed over time. Neurological deficits as measured by a variety of increasingly sensitive neurobehavioral tests represent one such outcome, and the development of a parkinsonian syndrome among welders exposed to manganese fume presents a specific instance. Welders employed in the construction of piers for a new San Francisco-Oakland Bay Bridge in San Francisco were previously evaluated using a broad spectrum of tests. Results for four of those tests (Rey-Osterrieth Complex Figure Test, Working Memory Index, Stroop Color Word Test and Auditory Consonant Trigrams Test) were used in the benchmark dose procedure. Across the four outcomes analyzed, benchmark dose estimates were generally within a factor of 2.0, and decreased as the percentile of normal performance defining impairment increased. Estimated excess prevalence of impairment, defined as performance below the 5th percentile of normal, after 2 years of exposure at the current California standard (0.2mg/m(3), 8h TWA), ranged 15-32% for the outcomes studied. Because these exposures occurred over a 1-2-year period, generalization to lifetime excess risk requires further consideration of the form of the exposure response and whether short-term responses can be generalized to equivalent 45-year period. These results indicate unacceptable risks at the current OSHA PEL for manganese (5.0mg/m(3), 15min) and likely at the Cal OSHA PEL as well. 
KeywordsNeurological-system; Neurological-reactions; Occupational-exposure; Risk-factors; Risk-analysis; Welders; Welding; Welding-industry; Occupational-health; Occupational-diseases; Diseases; Exposure-assessment; Manganese-compounds 
ContactCenters for Disease Control and Prevention, National Institute for Occupational Safety and Health, Education and Information Division, MS C-15, 4676 Columbia Parkway, Cincinnati, OH 45226, USA 
CODENNRTXDN 
CAS No.7439-96-5 
Publication Date20060501 
Document TypeJournal Article 
Email Addressrhp9@cdc.gov 
Funding TypeConstruction 
Fiscal Year2006 
NTIS Accession No. 
NTIS Price 
Issue of Publication
ISSN0161-813X 
NIOSH DivisionEID 
Source NameNeurotoxicology 
StateOH 
Page 1 of 2